The task is to evaluate two gates based on the earnings call transcript and return YES only if both are YES, otherwise NO. NO The transcript shows positive current developments around emavusertib's enrollment and data progress, but the Q&A mostly restates prepared remarks or shifts to generalities like market size, partnering interest, and data expectations without adding new operational specifics (e.g., exact site counts, precise volumes, or execution details beyond 20% CR bars). It fails Gate 1's additive, substantive criteria. Gate 2 would pass as the company's own drug and trial execution, but since Gate 1 fails, the combined answer is NO.
Curis, Inc.
The call grade, management's tone measured against 177,437 other calls, what changed since the quarter before, and every one of the 500 checks.
This is the current report. Unlock its call read, expected move size, and all 500 answers.
- Does the transcript contain the phrase "next question" at least twice?
- Does an analyst preface a question with "quick" or "quickly"?
- Are the CEO's prepared remarks longer than the CFO's, judged by speaker turns on the transcript page?
- Does management say "we are not going to comment on" or equivalent refusal language?
30 markers, measured against 177,437 calls
Language counted straight from the transcript, behaviour read by the 500 checks, tone above. The band is the middle half of every call we have graded; a flag means this call sits outside it.
All 500 AI checks
Q4 2025 · 500 checks
Every answer is below. Open any check to see what its YES or NO means.
YES Does an executive answer a question by describing a process rather than an outcome?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is there a question the executive answers with a question back to the analyst?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone compare the company to an unnamed "competitor" or "peer" rather than naming it?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone use "historically" or "traditionally" while defending a current practice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is a departure, transition, or role change mentioned only in passing without a thank-you or tribute?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone reference a private conversation ("as I told...", "as we discussed offline")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the transcript contain the phrase "next question" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst ask a question spanning more than five sentences?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst ask a question containing multiple sub-questions (three or more)?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the CEO answer a question personally after another executive initially responds?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker use the phrase "if you look at" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst preface a question by summarizing the company's stated results?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker use the word "obviously" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "guidance" in the same sentence as a specific number?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst say "congrats" or "congratulations" to management?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is the word "scale" or "scaling" used as a verb?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an analyst ask a question beginning with a number ("two questions", "three quick ones")?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst say "thank you" before asking their question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst name two or more executives when asking their question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "outperform," "outperformance," or "beat" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "the environment" when describing market conditions?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive use the word "momentum" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive begin an answer with "Great question," "Thanks," or "Appreciate"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CFO use the phrase "adjusted" or "non-GAAP" at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "thank you" more than three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker say "with that" as a transition phrase?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone use the phrase "on a comparable basis" or "adjusted for"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "moving to" or "turning to" when changing topics?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker say "over to you" or "I'll turn it over"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker say "operator" aloud during the call?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone repeat the same stock phrase three or more times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone use the phrase "as you know" to introduce a claim?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker apologize without attaching a fix to the apology?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the call end without any closing statement from the CEO?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is there a request to move the call along or to the last question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive answer a question with another question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive mention the weather?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone describe a negotiation currently in progress?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive describe a competitor with anything resembling respect?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the operator announce more than ten questioners in the Q&A?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "kind of" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any question include the word "color"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the CEO deliver the opening remarks rather than the CFO or IR head?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone say "if I may" or "if you don't mind"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive's first sentence include the word "revenue"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst use the word "clarification" or "clarify" in a question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any question contain the phrase "color on" or "some color"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the operator use the phrase "our final question" before closing?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "let me" at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "aggressive" or "aggressively" appear at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst ask a question referencing "the puts and takes"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "to be clear"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst's question include a compliment followed by "but"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CFO use the word "sequential" or "sequentially" at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "with that" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "for the benefit of" or "just to remind" when restating context?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone use the phrase "early days"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "journey" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the speaker describe a strategy as "disciplined" without describing any trade-off?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is there an apology offered to a specific analyst by name?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone use the phrase "to be honest" or "frankly"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone promise to "follow up" or "take that offline" and fail to commit to when?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone on the call interrupt a colleague mid-sentence?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does someone use a personal anecdote rather than a metric to justify confidence?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "question" appear in the operator's speech more than three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "growth" appear at least ten times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone use the phrase "a couple of"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst ask about capital allocation or buybacks?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the word "strong" at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive use the phrase "we're seeing" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "opportunity" appear at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the word "confident" or "confidence" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "record" appear at least twice in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "team" appear at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does management promise to follow up or take a question offline?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "we're excited about" or "we're pleased with"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Do two or more analysts from the same firm ask questions?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "moving forward" or "go forward"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management mention a specific number of stores, locations, or markets?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the word "folks"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "thank you" more than five times in total?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an executive use the phrase "we believe"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the operator use the phrase "next question" at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst mention a specific percentage figure in their question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "quarter" appear in at least ten questions or answers during the Q&A?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does at least one analyst ask a question about margins or costs?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the CEO answer the majority of analyst questions personally?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst ask a question phrased as "Can you talk about" or "Can you speak to"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CFO speak during the Q&A portion at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any question reference a specific quarter (e.g., "fourth quarter") by name?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the operator interrupt the Q&A to announce time is limited or that this will be the last question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst ask a question beginning with "just" (e.g., "just curious")?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst ask about a specific dollar amount or number stated in the prepared remarks?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any question begin with the words "can you" or "could you"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive use the phrase "if you look at" during the Q&A?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the CFO answer at least one question without the CEO speaking first?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst ask a question containing an explicit comparison to a competitor company?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the phrase "moving on" or "next question" come from the operator?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst ask about capital allocation (capex, buybacks, M&A, or dividends) in one question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "color" appear (e.g., "add some color") in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "guidance" appear at least five times in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any question contain the word "why"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker say "I think" at least three times within a single answer?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive begin an answer by restating the analyst's name?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any executive's answer exceed 300 words in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the CEO answer the first analyst question personally?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "obviously" appear in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the transcript contain the word "margin" more than ten times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive begin an answer with "So" as the first word?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "if I may" or "if I could" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive say "let me" at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any question contain the word "specifically"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the word "momentum" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management mention "margin" or "margins" in prepared remarks?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is the word "definitely" used by any speaker?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "seasonality" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the word "robust" to describe demand, growth, or the pipeline?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the word "leverage" as a verb at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive use the word "team" when referring to employees?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any executive say "that said" or "having said that" to introduce a caveat?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst's question include the phrase "going forward"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive say "great question" at any point?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "we remain confident" or "we are confident"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive say "thank you" immediately after finishing an answer?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an executive cite a specific dollar figure greater than one billion?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst's question contain the word "curious"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an analyst reference a specific prior quarter by name (e.g., "last quarter")?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker say "obviously" two or more times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst ask a follow-up in the same turn after their first answer?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst ask about a specific geographic region or market?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst ask a question that includes the phrase "long term" or "long-term"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "margin" or "margins" appear at least five times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "opportunity" or "opportunities" appear at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive say "we'll come back to that" or defer an answer to a follow-up?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "thank you" three or more times in the Q&A section?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CFO use the phrase "free cash flow" at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive use the word "momentum"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the CEO mention at least one specific customer segment by name (e.g., "enterprise")?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the phrase "take your question" or "take the question" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst introduce themselves by name before asking their first question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone say "including" at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management reference "the macro environment" or "macroeconomic" at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive reference "our team" or "the team" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the operator announce more than one analyst from the same firm?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any prepared remark mention "headwinds" or "tailwinds"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "with that, I'll turn it over"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CFO use the phrase "capital allocation"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive decline to answer, citing that something will come later or is not disclosed?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst ask a two-part question containing the word "but"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone ask a follow-up question in the same turn after their first question is answered?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone answer "yes" or "no" as the first word of a response?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "thank you" at least ten times in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive use the phrase "if you look at" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst begin their question with "Hi" or "Hello" as a greeting?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "we are excited about" without naming a number?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst reference a peer company's results or valuation?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use the phrase "just to clarify" or "just to be clear"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the word "headwind" or "headwinds"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use the word "tailwind" or "tailwinds"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use the word "momentum"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "investments" appear in the context of margins or costs?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone mention "FX" or "foreign exchange"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "efficiency" or "productivity" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an analyst thank the executives or congratulate them before asking a question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive say "great question" or "thanks for the question"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive say "as we said last quarter" or reference a prior call?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the phrase "going forward" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the word "levers" when discussing actions?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management thank analysts by name at any point after a question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "we'll take that offline" or offer to follow up after the call?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the word "committed" regarding a target?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CEO's prepared remarks mention "macro" or "macroeconomic"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "the vast majority"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "temporary" or "transitory" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is an analyst's question answered with "great question" or similar?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is there a questioner from an investment bank other than the first three analysts who ask questions?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst ask a question that includes a reference to a specific dollar figure?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone say "thank you" at least ten times across the call?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "thank you for taking my question" or "thanks for taking my question" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst's first sentence contain a compliment or thanks before asking their question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the CFO present in both the prepared remarks and the Q&A portion of the call?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the CEO personally deliver the closing remarks of the call?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CEO's prepared remarks contain the word "team" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker use the phrase "moving on" or "with that" to transition between topics?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the phrase "in terms of" appear at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO First-person singular ("I believe," "I think") used more by the CFO than the CEO.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES A single question receives answers from two different executives.
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES A hedge word ("maybe," "sort of") appears inside a direct quantitative claim.
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker use the word "obviously"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "guidance" appear in both prepared remarks and the Q&A section?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive defer a question to another executive by name?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Someone uses the word "honestly," "frankly," or "to be clear."
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone use the word "ecosystem" or "platform" without a number attached?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the transcript contain the word "certainly" three or more times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone begin an answer by restating or paraphrasing the analyst's name?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst reference a competitor by name during their question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does a speaker say "let me" at least twice in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO The transcript contains an apology unrelated to financial results.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO The word "challenge" is spoken more often than "opportunity."
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "seasonality" or "seasonal" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES The phrase "as you know" appears at least twice.
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker use the word "challenge" or "challenges" at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone mention "weather" as a factor affecting results?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive say "thank you" to the analyst before answering a question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker say "great question" or similar praise of a question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES The final question is answered noticeably shorter than the opening ones.
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone say "we remain" followed by a verb (e.g., "we remain committed")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive cite a conversation with a customer that has no verifiable specificity (unnamed, undated, unquantified)?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the transcript contain a sentence that begins with "What I would say is"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any question mention a specific percentage or dollar figure?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the CEO personally answer more questions than any other executive?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the operator say "our final question" or similar?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "opportunity" or "opportunities" appear at least five times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "clearly" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "leverage" appear as a verb at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst's first name get used by an executive when thanking them?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the operator announce more than five questioners?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Are there more than ten analyst questions in total?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the operator use the phrase "our next question comes from" more than three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Are the CEO's prepared remarks longer than the CFO's, judged by speaker turns on the transcript page?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does management say "we are not going to comment on" or equivalent refusal language?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Executive corrects an analyst's premise.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CFO's prepared section exceed the CEO's in number of paragraphs?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the CEO personally answer more than half of the analyst questions?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst mention the word "margin" in their first question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Executive uses the word "excited" more than twice.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst ask a multi-part question containing three or more distinct questions?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "guidance" appear at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst ask a two-part question signaled by "and also" or "and secondly"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an analyst begin with a compliment, such as "great quarter" or "congrats"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an executive say "we said" when recalling prior statements?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst begin their turn with "thanks" or "thank you"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "headwind" or "tailwind" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "synergies" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst address a question to two or more executives by name?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "capital" appear at least five times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive say "we feel" rather than "we believe" or "we think"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "capital" appear in at least three different speakers' turns?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive use the phrase "over time" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive say "as I mentioned" or "as we said" at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CEO open the call before any analyst questions by mentioning the macro environment?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "we are pleased" or "we're excited"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone use the word "leverage" (financial or metaphorical)?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an analyst thank management before asking their question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is the word "automation" or "productivity" used at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "uncertainty" or "uncertainties" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "year over year" appear at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the word "leverage" or "leveraging" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Currency headwinds mentioned unprompted.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is the phrase "a number of" used at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone use the phrase "best-in-class" or "industry-leading"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "momentum" appear at least twice in prepared remarks?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the phrase "on a constant currency basis" or similar currency adjustment used?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst's question include the phrase "just to clarify"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "the team" appear at least twice in management remarks?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker say "so clearly" or "quite frankly"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the phrase "we believe" at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Speaker says "we don't guide" on anything.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CFO use the word "quarter" at least ten times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "thank you" more than five times in total?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "macro" or "macroeconomic" appear at least twice in the call?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the transcript contain the word "typically" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive state they will "come back to" a question or follow up later?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management thank analysts for their questions at any point during Q&A?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Speaker admits being surprised by anything.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use the phrase "going forward"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the phrase "going forward" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "stability" or "stable" when describing demand?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Word "normal" used about demand.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive say "stay tuned" or "more to come"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management describe a cost program, restructuring, or efficiency initiative by a proper name?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CFO's prepared section mention interest expense by name or figure?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "volatility" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Executive mentions a hobby or personal anecdote.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "pipeline" appear without a dollar figure attached?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the phrase "the macro" or "macro environment" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "our team" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive say "great question" or "good question" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker say "we remain" followed by an adjective?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management thank analysts by name when responding?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "flexibility" or "flexible" used at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "takeaway," "take out," or "take rate"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Analyst compliments the team before asking a question.
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker use "we're" where "we are" could substitute, more than twenty times overall?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst reference the CEO or CFO by first name?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "obviously" at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone use the word "pipeline" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "moving on" or "let me turn it over" during prepared remarks?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an analyst ask a question starting with "just"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone say "headwind" or "headwinds" more than once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst use the phrase "to clarify"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive use the phrase "year over year" at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive cite a conversation with a customer, partner, or employee as evidence?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any question go to a named executive other than the CEO or CFO?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive say "to be clear" or "let me be clear"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone mention a competitor by name without being prompted?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is there a question that management declines to answer directly, citing timing or disclosure constraints?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any question explicitly reference the company's prior guidance or outlook?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker say "next question" or does the operator use the word "final" before the last question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "invest" or "investment" appear at least five times in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CFO handle a strategic question instead of a financial one?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an analyst flatter management within their first sentence of speaking?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst ask two questions when told to ask only one?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "underlying" to modify a business metric?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "excited" or "pleased" at least twice in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "guidance" appear in the prepared remarks (not just Q&A)?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "margin" used with a number attached (e.g., "400 basis points")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the transcript contain the word "record" preceding a noun (e.g., "record margin")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive answer a question by citing a competitor's actions?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "macro" or "macroeconomic" appear in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "challenges" appear more than once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CEO begin an answer with "look" or "listen"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "inflation" appear anywhere in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is there a pause or silence acknowledged on the call ("I think we lost you")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive name a specific competitor during the call?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "challenges" appear at least three times in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "we don't break that out" in response to a question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone describe a metric as "noisy" or "lumpy"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive mention a specific number of percentage points when discussing market share?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does a speaker correct a figure they themselves just stated?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CEO refer to a competitor by name rather than "competition" or "peers"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CEO mention their own tenure or years of experience unprompted?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone use the phrase "the team" when taking ownership would be natural?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone blame weather, holidays, or calendar quirks unprompted?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone cite a personal anecdote involving a customer conversation?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone use the phrase "a little bit"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Is the CFO the speaker for at least one analyst question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "guidance" appear in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "we're excited" or "we are excited"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "dividend" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "invest" or "investment" used more than twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "invest" or "investment" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone cite a percentage of revenue from a specific segment?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "challenge" or "challenging" appear at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone describe cutting discretionary spending like travel or hiring?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the phrase "year over year" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "liquidity" appear at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the transcript mention refinancing, maturity dates, or debt coming due?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone mention selling assets, real estate, or equipment to raise cash?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone reference "the macro" or "macro environment"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "capacity" mentioned?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "our customers" rather than naming a customer?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the transcript include a question about interest expense or debt service?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "working capital" appear in a context other than a seasonality excuse?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management thank analysts at any point?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone reference borrowing from a bank or drawing on a credit facility?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "cost" appear in the first ten sentences of prepared remarks?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive say "we remain confident" or similar?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone mention covenants, amendments to loan documents, or lender conversations?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "with that" or "that said" to pivot?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive open their first answer by thanking the analyst?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst's question include the word "capex" or "cash flow"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "headline" or "headwinds" appear at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "core" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst's turn contain the word "congratulations"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst ask a question containing "how" and also "why"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive say "as we mentioned" or "as I mentioned" at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Are there more than eight analyst questioners?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst's question include a percentage figure?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst's question contain the word "guidance"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CFO's prepared remarks exceed 1,000 words?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker say "if you look at"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the CEO personally answer the first question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker use the phrase "tailwind" or "tailwinds"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the phrase "balance sheet" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the CEO make closing remarks after the Q&A ends?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker say "structurally" or "secular"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the operator say "our next question" two or more times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the final questioner get an explicit closing acknowledgment from the operator ("last question" or similar)?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does management use the phrase "business as usual" or "as expected" at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an analyst preface a question with "quick" or "quickly"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive state a specific numeric percentage when answering a question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "in terms of" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is there a question that clearly annoyed the executive, visible in the reply's abruptness?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "guidance" appear in the Q&A section?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "strong" appear more than five times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "thank you" appear more than ten times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst ask a question containing the word "margin"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the word "guidance" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "thank you" appear at least ten times anywhere in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive begin an answer by restating the analyst's name?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst ask about capital allocation or share repurchases?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "challenge" or "challenging" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "opportunity" or "opportunities" appear more than three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is there a villain—market conditions, regulation, currency—that behaves consistently across the call?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "challenging" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "certainly" appear at least once in management's answers?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst ask a personal, warm, or congratulatory question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the phrase "capital" appear at least five times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst ask a question the prepared remarks already answered?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "quarter" appear at least twenty times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any single analyst ask more than two questions during the whole call?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the phrase "on a year-over-year basis" or "year over year" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "headwinds" or "tailwinds" used?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "margin" appear at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "confidence" or "confident" spoken by any executive?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "call it" or "let's call it" before an estimate?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "going forward" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "coming back" or "circling back" to take a follow-up?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "inflation" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive say "we believe" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the phrase "going forward"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the word "robust"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use the phrase "if you will" or "so to speak"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "appreciate" at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone use the phrase "at the end of the day"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone tell a self-contained anecdote with a beginning, middle, and end?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive use the phrase "our team"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the transcript contain a silence, pause, or "we'll come back to that" that never resolves?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone describe a customer, employee, or competitor as a named character with a motive?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive say "we're pleased" or "I'm pleased"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is there a moment of modesty—someone crediting luck or timing?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "on a year-over-year basis"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is the word "excited" or "exciting" used by management at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker say "just" five or more times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any question begin with "Can you" or "Could you"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "quick" or "quickly" appear in three or more analyst questions?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst ask for guidance on a metric management did not offer unprompted?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is there a question about capital allocation (buybacks, M&A, debt, or dividends)?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst use the word "clarify" or "clarification"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "obviously" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management refer to a prior call or prior quarter's commentary when answering?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone use the word "actually" at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive begin an answer with "Look," or "So,"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "challenging" or "challenges" appear at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the operator run out of queued questions and close early?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst apologize or preface with "sorry" before asking?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is the word "excited" used by the CEO more than the word "confident"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker use the phrase "the right" before a noun ("the right team," "the right decisions")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "guidance" appear more than five times in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "tailwind" or "headwind" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst's question begin with a compliment or congratulation?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst apologize before or during their question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Are there more questions about revenue than about costs?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "challenging" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use the phrase "on a" four or more times total (e.g., "on a constant currency basis")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive answer begin with "Sure" or "Yes" followed by a comma?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "from a ... perspective" (e.g., "from a margin perspective")?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an executive say "we're not going to" in response to a question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management decline to answer by citing a future event ("we'll address that in..." or "at our upcoming...")?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "quarter" appear at least 20 times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is there a mention of "FX," "currency," or "foreign exchange"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive say "that's right" or "that's correct" to an analyst?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "leverage" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "leverage" used at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the word "headwinds" at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "great question" or thank the analyst before answering?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone attribute results to "the team" rather than to strategy?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker say "going forward"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst begin their question with "congratulations"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an analyst thank management at the end of their turn?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone describe the future with "We believe" more than "We expect"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does a speaker say "normal" or "normalized" about conditions that predate any disruption mentioned?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "momentum" used without a stated metric attached to it?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "macro" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management use the word "solid" at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is there an analogy to a machine, engine, or flywheel?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "visibility" used at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the phrase "base case" or "scenario" used at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "we take that seriously" or "we're very focused on"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is the phrase "to your point" or "as you mentioned" used at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the operator say "thank you" more than three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management mention a specific competitor by name?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management say "the team" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "fundamentally" appear at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the phrase "ahead of" precede any mention of guidance or expectations?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the phrase "on a year-over-year basis"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any single speaker say "right?" as a tag question at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the phrase "on a consistent basis" or "consistently"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does a speaker begin a sentence with "To be honest" or "To be clear"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the phrase "strategic" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker describe a business unit as "healthy"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use the word "fundamentals"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "resilient" or "resilience" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the operator mention a queue or "next question" more than three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst ask a follow-up after their initial answer ("follow-up", "second one", "just one more")?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst ask a question containing the word "why"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "if you look at" before citing a number?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "last question" or "final question" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "clearly" appear anywhere in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the CEO speak first among named executives in the Q&A?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "headwind" or "headwinds" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the CFO mention a specific percentage greater than ten?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the phrase "going forward" appear at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "team" appear at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "confident" appear in any executive's remarks?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an analyst thank management at the start or end of their turn?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CEO use the word "incredibly" at any point?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive use the word "team" to refer to company personnel?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone say "to your point" when answering a question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive say "with that" to transition between speakers or topics?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "transformation" or "transformational" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker say "moving on" or "next question" themselves?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use the word "hedging" or say "to hedge"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst identify themselves with a two-part introduction (name and firm)?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "talent" appear at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "capacity" used more often about factories than about people?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive confess to having too much of something physical somewhere?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is a supplier or vendor mentioned by name at any point?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any executive blame weather, season, or geography for a shipment or delivery issue?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
Archived AI reasoning
Earlier Artul research experiments on CRIS calls. Open a question to read the model's original reasoning.
NO Answers go deeper than the script: questioning keeps surfacing new concrete detail behind a positive development — compa
Original model output from the research archive. It may be verbose or include the model's working notes.
We need answer only YES or NO. Need evaluate both gates. Let's analyze transcript. Gate 1: Positive current development? Management highlights three clinical programs, but are they "current" positive developments? They are ongoing clinical trials, data updates. The Q&A probes: fimepinostat combo with venetoclax planned, CA-170 mesothelioma study planned, etc. Are these current developments or plans? Management says "we are currently working with FDA to initiate" etc. The positive development is perhaps the clinical programs themselves, but the Q&A adds details? Let's see. Prepared remarks: fimepinostat has data, Fast Track, plan combo with venetoclax, start enrolling 1H2019, efficacy data 2H2019. CA-4948 early data, CA-170 plan mesothelioma. Q&A: Adnan asks about priority, data updates. Jim says not priority, etc. Then fimepinostat hurdle: Bob adds preclinical models, combination. Peter asks about CA-170 next update, VISTA, mesothelioma patients. Jim says SITC, etc. Bob adds VISTA expression on tumor cells, resistance mechanism, no diagnostic needed. Then fimepinostat registrational studies: Jim says conversations with FDA, tested combos, BCL2, etc. Brian asks about trial design, Double Hit vs Double Expressor, Bob answers enrollment parameters. Then CA-170 dose: Bob explains bell-shaped curve, lower dose, escalation. Are these "current" developments? The main positive is the clinical pipeline, but much is plans. However, there is existing data and ongoing studies. The Q&A does add specifics about trial design, VISTA biology, dose rationale. But is it "concrete operating detail" about actual current activity? It's more about planned trials and scientific rationale. The prepared remarks already said plans. The Q&A adds some specifics but not necessarily "real and current" business activity. Also the development is not a commercial ramp; it's clinical development. The question asks "positive, current development in company's business — some part of the business that management presents as genuinely going well or stepping up right now" — perhaps the clinical programs are going well. But the Q&A discussion produces more concrete operating detail? Let's see. Gate 1 requires: development being discussed is REAL AND CURRENT — actual business activity, demand, execution, or progress already happening now, not a plan, hope, or market opportunity.
The transcript is about Curis, Inc.'s Q2 2018 earnings call. Let me analyze the two gates. Gate 1: Is there a positive, current development that the Q&A produces more concrete operating detail about than the prepared remarks? The prepared remarks discuss fimepinostat (a lead clinical candidate), CA-170, and CA-4948. The Q&A focuses on fimepinostat trial design discussions with FDA, CA-170 updates at conferences, and mesothelioma. Let me look at the Q&A: - Adnan Butt asks about fimepinostat trial design discussions. Ali Fattaey responds that they are continuing discussions, expect to run a randomized controlled trial, FDA encouraging. When asked about finalizing, he says they have preliminary work to do, combining with regimens, sizing will be determined later. This is somewhat vague - not much new concrete detail. - On CA-170, asked about medical meeting updates. Ali says SITC Conference is appropriate, expects to present data. When asked about Phase 1 and Phase 2 data, he says they would like to present full clinical profile. When asked about whether updates come at medical meetings or company updates, he says preference is scientific conference. - On mesothelioma, he clarifies that investigators presented work at ASCO showing mesothelioma over-expresses VISTA, and they want to enroll patients with mesothelioma in second half of year. The Q&A doesn't really add much concrete operating detail beyond the prepared remarks. The prepared remarks already covered the fimepinostat combination plans, CA-170 BID dosing, VISTA expression, and mesothelioma plans. The Q&A answers are mostly restatements or generalities. For example, on fimepinostat trial design, the answer is "we continue to work through those" - not much new. On CA-170, the answers are about conference presentations, not new operating detail. The Q&A doesn't seem to produce more concrete detail than the prepared remarks. The answers are somewhat general and don't add substantial new specifics about actual operations, volumes, timing, etc. Gate 1: The development being discussed (fimepinostat combination trials, CA-170 progress) is real and current, but the Q&A doesn't add much new concrete detail. The answers mostly repeat or are general. So Gate 1 would be NO. Gate 2: Even if there were a positive development, the engine is the company's own clinical development, which is internal.
NO New audience on the call: management says a different kind of buyer has recently arrived and is now paying real money
Original model output from the research archive. It may be verbose or include the model's working notes.
We need answer yes/no based on transcript. Need determine if management describes new kind of paying counterparty recently begun doing real business, meaningful new leg. Let's parse. Company Curis, biotech. Revenue from Erivedge royalties from Genentech/Roche. Programs CUDC-907, CA170, IRAK4. Need see if management describes new kind of customer/market/buyer recently begun transacting. Maybe CA170 entering clinic? Not paying. CUDC-907 Phase 2? Patients? No. Erivedge new studies in myelofibrosis/IPF by Roche? That's new indications, but not paying counterparty? Actually Erivedge is commercialized by partners; Roche initiated studies outside BCC. That could be new patient groups/end markets? But are they "recently begun doing real business" with company? No, studies are clinical trials, not paying orders. Management mentions as partner activities, not revenue. Question asks "new kind of paying counterparty has RECENTLY begun doing real business with the company — a type of customer, market, or buyer that was not part of how this company historically earned its money — and does management treat this arrival as a meaningful new leg of the business rather than a curiosity?" Need answer YES only if management's own words convey one coherent development: composition of who pays company has recently broadened in kind, and new kind already transacting. Examples: different industry now buying; larger class customer; new geography; new patient group/end market/application segment now being served; distribution relationship; second distinct source of revenue emerging. In transcript, management discusses: - CUDC-907 Phase 2 trial in DLBCL patients with MYC alterations. This is a new patient group? But patients don't pay; they are trial participants. Not paying counterparty. - CA170 entering clinic. Not paying. - Erivedge: Roche initiated two clinical studies outside BCC: myelofibrosis and IPF. This is new indications, but not "paying" yet. Also Erivedge is already commercialized by partners; royalties from sales. New studies are not revenue. - Financial results: revenues $1.7 million from royalties on Erivedge. No new revenue source. - Maybe "new kind of paying counterparty" could be "patients" in clinical trials? No, they don't pay. - "customers" in biotech are partners/licensees? Genentech/Roche are existing. Aurigene collaboration? Not paying? They issued shares. No.
NO Disproportional response: a small company's current business is visibly outgrowing its own size
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to answer YES or NO based on the transcript. The question asks: does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That is, does management describe current activity, demand, or commitments arriving at a scale that is large relative to how small the company still is, so that the reported results look like the early portion of something meaningfully bigger rather than a full picture of the business? We need to look for management's own words conveying a disproportion between the company's size and what is currently arriving or being committed to it. This must be grounded in real, present-tense business, not just market-size statistics or hopes. Let's examine the transcript. The company is Curis, a biotech. They have two advanced programs: CUDC-907 (a drug for DLBCL) and CA170 (an oral checkpoint inhibitor). They also have Erivedge royalties. Management discusses progress: CUDC-907 Phase 2 trial ongoing, enrollment completed in monotherapy arm, responses observed. CA170 expected to enter clinic later this quarter. Erivedge royalties from Genentech/Roche. Does management convey that the current business is disproportionately large relative to the company's size? The company is small (market cap? not given, but they have $73M cash, 129M shares). They are a development-stage biotech with no product revenue except royalties. The question is about current activity, demand, commitments arriving at a scale large relative to the company's smallness. Look for statements like: "we have now completed enrollment", "eight patients have experienced an objective response", "we expect CA170 to become the world's first orally administered checkpoint targeting immunooncology drug candidate to enter the clinic." That's about a milestone, not about scale of business. The question is about whether the business is outgrowing the company's size. For a biotech, that might be if they have a huge market opportunity, but that's prospective. Or if they have a partnership that brings in large commitments. But here, they have royalties from Erivedge, but that's not described as disproportionately large relative to the company. Management does not explicitly contrast the company's small size with the scale of what is arriving. They talk about clinical progress, but that's not about business scale.
NO Deliveries running ahead of the money: management is already handing over more than it has been paid for
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to determine if management describes that the physical/operational side of the business is already running at a higher level than the financial side has recognized. That is, real work is going out the door at a higher level than revenue reflects, and management treats this gap as real and closing. Let's analyze the transcript. The company is Curis, a biotech. They have programs: CUDC-907 (a drug in clinical trials), CA170 (a drug about to enter clinic), and Erivedge (commercialized by partners). Revenue is from royalties on Erivedge. The company is not yet generating revenue from its own drugs; they are in development. The question asks about physical/operational side running ahead of financial recognition. In a biotech, revenue might be from partnerships, milestones, etc. But here, revenue is royalties from Erivedge. The company's own operations are R&D, not producing revenue. The question is about "producing, delivering, installing, serving, treating, staffing, shipping, or otherwise handing over MORE real work than the revenue in the reported period reflects." In this context, the "real work" could be clinical trials, but that doesn't generate revenue. The company is not selling anything. The revenue is from royalties, which are based on partner sales. There is no indication that the company is doing more work than revenue reflects. The company is spending on R&D, but that's not revenue-generating. The question is about a gap between physical output and recognized revenue. Here, there is no physical output that will be recognized later. The company is a development-stage biotech. The only revenue is royalties from Erivedge, which are recognized as they are earned. There is no deferred revenue or work in progress that will be recognized later. The management discusses clinical trials, but those are costs, not revenue. They don't mention any situation where they are delivering something now that will be billed later. So the answer is NO. Let's double-check: The transcript mentions "we have now completed the enrollment in the monotherapy arm of the Phase 1" etc. That's about clinical progress, not revenue. The company's revenue is from royalties, which are based on partner sales. There is no mention of any deferred revenue or work in progress. The question is about a specific phenomenon where the operation is running ahead of the income statement.
NO Bought the ticket, hasn't taken the ride: the company has already paid for its next stage and is now waiting to be paid
Original model output from the research archive. It may be verbose or include the model's working notes.
The question asks whether management describes a situation where the company has already spent or irreversibly committed resources for a stage of business it has not yet been paid back for — i.e., spending is done, return is outstanding, and payback is treated as a matter of time. Let me examine the transcript for evidence of this pattern. Key points from the call: - CUDC-907 Phase 2 trial initiated in January 2016, enrollment ongoing. The Phase 1 monotherapy arm is complete (25 patients, 8 responses). The Phase 2 is ongoing. - CA170 is expected to enter the clinic later this quarter (Q2 2016). It's not yet in the clinic. - R&D expenses increased due to "increased direct spending related to outside services supporting the ongoing clinical activities of CUDC-907, including initial costs for the Phase 2 trial that was initiated in January 2016 and direct costs for programs under the Aurigene collaboration." So the company has spent money on the Phase 2 trial (initiated January 2016) and on the Aurigene collaboration programs. The Phase 2 trial is ongoing — the spending is happening, but the results (payback) are not yet in. The company expects to present data potentially at ASH this year or 2017. Is this a case where the spending is done and the return is outstanding? The Phase 2 trial is ongoing — it's not complete. The spending is ongoing, not fully done. The trial is still enrolling. So the spending is not "done" — it's in progress. For CA170, it's expected to enter the clinic later this quarter — so the spending on that is still ahead, not done. The question asks about a situation where the company has ALREADY PAID for something and the return is still outstanding. The Phase 2 trial is ongoing — the spending is happening now, not completed. The return (data, potential approval) is in the future. But is the spending "done"? No, the trial is still enrolling and running. The spending is ongoing, not completed. Also, the payback for a clinical trial is not really a "matter of time" in the sense of a business that has built capacity and is waiting for it to fill — it's more about clinical trial results, which are uncertain. The company is spending on R&D, which is normal investment in a biotech. The returns (drug approvals, sales) are far off and uncertain. The question's criteria: "THE SPENDING IS DONE, NOT PLANNED" — the Phase 2 trial is ongoing, not done.
NO Cost per customer just fell off a cliff: the company's own selling and acquisition engine is getting cheaper as it grows
Original model output from the research archive. It may be verbose or include the model's working notes.
We need answer only YES or NO. Need determine if management conveys that cost to win/serve each new unit business has materially decreased, already realized, not future. Need parse transcript. We need evaluate. The question asks: "On this call, does management convey that IT NOW COSTS THE COMPANY MATERIALLY LESS EFFORT OR MONEY TO WIN AND SERVE EACH NEW UNIT OF BUSINESS THAN IT USED TO — that the company's own machinery for finding, closing, onboarding, or supporting customers is getting cheaper per customer even as volume rises — and does management present this as an already-observed change in the company's current operating experience rather than an expected benefit of future scale?" Need answer YES/NO based only transcript. Let's read transcript. It's Curis Q1 2016 earnings call. Management discusses CUDC-907, CA170, Erivedge. Financial results. No explicit customer acquisition cost etc. Need see if any statement conveys unit economics improving. Maybe "R&D expenses increased due to outside services supporting ongoing clinical activities" not cheaper. "G&A increased." No. Maybe "we have now completed enrollment... eight patients..." Not about cost per customer. "CA170... first orally administered small molecule checkpoint antagonist" maybe oral administration cheaper? But not about company's cost to win/serve customers. "Erivedge commercialized by partners" no. Need be careful: The question is about "cost to win and serve each new unit of business" i.e., customer acquisition/onboarding/support. In biotech, "unit of business" could be patients? But no. Maybe management says "we expect patient enrichment to increase probability of successful Phase 2" not cost. "We have now limited enrollment to patients with MYC alterations" maybe reduces trial cost? But not described as already realized? Hmm. Let's examine all statements. Opening: "Our most advanced program is CUDC-907... Phase 2 clinical trial... As a reminder, last December at ASH... Phase 1... 22 patients... reported seven objective responses out of 16 evaluable. As of today, we have now completed enrollment in monotherapy arm... total 25 patients... eight patients have experienced objective response out of total 19 response evaluable. Note that this does not include one complete response... In addition, retrospective analysis... clinical benefit may be related to inhibition of MYC oncogene...
NO Already spoken for downstream: customers are buying to fulfill business they have already secured
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to determine if management conveys that the company's customers are buying from the company to serve business those customers have already secured on their own side. The company is Curis, a biotech developing drugs. Customers? In this context, the company's customers are likely partners like Genentech/Roche for Erivedge, or patients? But the question is about the company's customers buying from the company to serve business they have already secured. For a biotech, the "customers" might be the patients or the partners? Actually, the company's revenue comes from royalties on Erivedge sales by Genentech/Roche. So the customers are the patients? Or the partners? The question is about the company's customers buying from the company to serve business those customers have already secured. In this case, the company's product is Erivedge, sold by Genentech/Roche. The demand behind what the company sells is already committed on the far side of its customers? That would mean that the patients or the doctors have already committed to using Erivedge? But the transcript doesn't really talk about that. Management mentions that Roche has initiated two clinical studies with Erivedge outside of BCC. That is about new studies, not about existing commitments. The company's main programs are CUDC-907 and CA170, which are in clinical trials. The company is not selling these yet. So the question is about whether management conveys that the company's customers are buying from the company to serve business already secured. For a biotech in development, the "customers" might be the patients in trials? But that doesn't fit. The question is likely about the company's partners or the end market. However, the transcript does not describe any situation where the company's customers have already secured business that drives purchases from the company. The company's revenue is from royalties on Erivedge, but management doesn't discuss the demand for Erivedge being driven by commitments already in place. They mention that Roche has initiated studies, but that's about new studies, not about existing sales. The company's own programs are in clinical trials, so no sales yet. The question asks: "does management convey that the company's customers are buying from the company to serve business those customers have ALREADY SECURED on their own side?" There is no such description.
NO Fresh evidence outrunning the reported numbers
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to answer YES or NO based on the transcript. The question asks: Does management repeatedly ground its case for the company's future in operating facts that are both fresh and early — concrete business developments that (a) began, occurred, or first became visible only within roughly the last quarter or two, (b) are already real today (actual orders, customers, shipments, openings, conversions, utilization, activity, or commitments in hand — not pipeline, interest, or plans), and (c) are explicitly described by management as only the BEGINNING of their contribution, with most of their effect still ahead of the reported results? We need to check if management does this. Let's review the call. Management discusses CUDC-907: Phase 1 completed enrollment, 25 patients, 8 responses. They mention a retrospective analysis correlating responses with MYC alterations. They designed Phase 2 to treat MYC-altered DLBCL patients. That study is ongoing. They also mention solid tumor trial limited to MYC-altered or NUT midline carcinoma. These are ongoing trials, not yet producing results that are "already real" in terms of revenue or significant activity? They are clinical trials, not business developments like orders or customers. The question is about operating facts like orders, customers, shipments, openings, conversions, utilization, activity, or commitments. Clinical trial enrollment is activity, but is it "fresh and early"? The Phase 2 trial was initiated in January 2016, so it's recent. But management does not say that the results reported capture only a small share of what these developments are expected to contribute. They talk about the trial being ongoing, but they don't explicitly say that the reported period understates the business as it now stands. They do mention that they expect to present data later, but that's not the same as saying the current results understate the business. For CA170: They expect it to enter the clinic later this quarter. That's a plan, not yet real. They say "we expect CA170 to become the world's first orally administered checkpoint targeting immunooncology drug candidate to enter the clinic." That's future, not past or present. So not a fresh fact that already happened. For Erivedge: Roche initiated two clinical studies. That's a development, but it's about partner's studies, not directly Curis's business results.
NO Position doing the winning: current wins credited to a standing already held, with more arriving over it
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to answer YES or NO based on the transcript. The question asks: On this call, when management explains why the company is CURRENTLY winning business, does it credit a STANDING THE COMPANY ALREADY HOLDS — something durable it built, secured, or became BEFORE this period — as the operative cause of wins that are actually happening now, AND does it convey that further business is already arriving over that same standing without a proportional new push? We need to analyze the transcript. The company is Curis, a biotech. They have programs: CUDC-907, CA170, and Erivedge (partnered with Genentech/Roche). The call is about Q1 2016 earnings. Management discusses CUDC-907: Phase 2 trial ongoing, they have completed enrollment in monotherapy arm, they report responses. They mention a retrospective analysis correlating responses with MYC alterations. They designed Phase 2 to target MYC-altered patients. This is about clinical trials, not necessarily "winning business" in a commercial sense. The company is a biotech with no commercial products except Erivedge royalties. Erivedge is commercialized by Genentech/Roche. They mention Roche initiated two clinical studies with Erivedge outside BCC. That's not about winning business. CA170 is about to enter clinic. Not yet. The question is about "winning business" - likely meaning revenue, customers, contracts, etc. In this context, the company's revenue is from royalties on Erivedge. They report revenues of $1.7 million for each quarter, primarily royalty revenues. They don't attribute that to a standing they hold; it's just existing royalties. Management talks about progress in clinical trials, but that's not "winning business" in the sense of customers or orders. The question might be interpreted more broadly: are they crediting an already-held standing (like a drug approval, a partnership, a technology) for current wins (like clinical trial progress, or partnerships)? But the question specifically says "winning business" - real orders, customers, contracts, volumes, or work in the recent period. In biotech, that could be partnerships, licensing deals, or product sales. Here, they have a partnership with Aurigene, but that was from 2015. They mention the collaboration. But they don't say that current wins are due to that standing. The question asks: "does it credit a STANDING THE COMPANY ALREADY HOLDS ...
NO Cheap-to-serve incremental business: management says the next tranche of volume costs it almost nothing extra
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to determine if management conveys that the cost of serving the next increment of business is unusually low because the company has already built and paid for the necessary resources, and that additional business of that kind is already arriving now. Let's analyze the transcript. The company is Curis, a biotech. They have programs: CUDC-907 (a drug in clinical trials), CA170 (a small molecule checkpoint antagonist), and Erivedge (commercialized by partners). They also have an IRAK4 inhibitor in preclinical. The question is about incremental business being cheap to serve because the base is already built and paid for, and that additional business is arriving. Look for any language about capacity, infrastructure, or fixed costs that are already in place and can handle more without proportional spending. Also look for evidence of increasing volume. In the transcript, management discusses clinical trials, enrollment, etc. They mention that CUDC-907 Phase 2 is ongoing, and they have completed enrollment in the monotherapy arm of Phase 1. They also mention CA170 is expected to enter the clinic this quarter. They talk about Erivedge being commercialized by partners. But is there any mention of "cost of serving the next increment" being low? For a biotech, the "business" might be drug development, but the question is about incremental business like additional patients, additional sales, etc. However, the company is not yet generating significant revenue from its own products; they have royalty revenue from Erivedge. Management does not discuss any capacity or infrastructure that is underutilized. They talk about clinical trials, but that's not about serving more business cheaply. They don't mention that they have already built a salesforce or manufacturing capacity that can handle more volume. They do mention that they have increased headcount in clinical development, but that's not about incremental business being cheap. The only revenue is from Erivedge royalties, which are from partners. They don't discuss any incremental business arriving. There is no mention of "already built and paid for" base that can carry more volume. The company is investing in R&D, which is spending. Thus, the answer is NO. We need to be careful: the question asks if management conveys that the cost of serving the next increment of business has become unusually low.
NO Bought the seat, waiting for the ride: management describes a position already secured inside someone else's decision, w
Original model output from the research archive. It may be verbose or include the model's working notes.
The question asks whether management conveys that the company's near-term growth no longer depends on persuading anyone, because decisions governing it have already been made by others, and the resulting activity has only just begun to reach the company. Let me analyze the transcript for the three conditions: (1) THE DECISION IS BEHIND THEM, NOT AHEAD OF THEM. Management describes the company's forward business as resting on choices outside parties have ALREADY made in its favor, so what remains is delivery rather than winning. Looking at the transcript: - CUDC-907: Phase 2 trial ongoing, designed to treat DLBCL patients with MYC alterations. The trial is ongoing, enrollment completed in monotherapy arm of Phase 1. This is a clinical trial, not a committed business from a customer. - CA170: expected to enter clinic this quarter. This is a drug candidate entering Phase 1. - Erivedge: commercialized by Genentech/Roche. Roche has initiated two clinical studies with Erivedge outside BCC. The company is a biotech developing drugs. The "decisions" here would be things like regulatory approvals, partnerships, etc. But the transcript doesn't really describe a situation where a decision has been made by an outside party that commits business to the company. Actually, let me think about this more carefully. The company has a collaboration with Aurigene (mentioned in the financials). It has a partnership with Genentech/Roche for Erivedge. But the transcript doesn't describe a situation where the company has been "chosen" and is now "racing to serve" a committed business. The company is running clinical trials - these are its own programs. The Erivedge royalties are ongoing but routine. (2) THE COMPANY IS BEHAVING LIKE SOMEONE PREPARING TO DELIVER. Management's account of what the organization is doing now is dominated by getting ready and getting it out the door. The transcript mentions: - R&D expenses increased due to clinical activities of CUDC-907, including initial costs for Phase 2 trial - Increased headcount - CA170 expected to enter clinic But this is standard drug development activity, not "preparing to deliver" against a committed order. (3) THE COMPANY IS SMALL RELATIVE TO WHAT HAS BEEN COMMITTED, AND THE NUMBERS DON'T SHOW IT YET. The company has $73.1 million in cash, net loss of $9.4 million. Revenues of $1.7 million from Erivedge royalties.
NO Priced for a smaller company: management is quietly telling investors the business has already outgrown what the numbers
Original model output from the research archive. It may be verbose or include the model's working notes.
The question asks whether management conveys that outsiders are currently underweighting something the company has already done, and whether management points to a concrete, already-completed or already-operating piece of the business whose contribution is still largely ahead of reported results. Let me analyze the transcript carefully. Key elements to look for: 1. A recognition gap management itself raises - management indicating that the way the company is seen/valued/measured doesn't match what the company already is. 2. A concrete, already-in-place thing that backs the claim, with its payoff still ahead. Let me go through the call: - Ali Fattaey discusses CUDC-907, the Phase 2 trial, the MYC alterations correlation, the Phase 1 data with 8 responses out of 19 evaluable patients. - He discusses CA170, the oral small molecule checkpoint antagonist, expected to enter clinic this quarter. - He discusses Erivedge and Roche's new studies. Now, does management raise a recognition gap? Let me look for any statement about how the company is perceived, valued, measured, or modeled. Looking at the discussion of CUDC-907: "we designed our Phase 2 study of CUDC-907 to specifically treat the roughly one-third of DLBCL patients who have MYC alterations based on the criteria that we indicated. We expect this patient enrichment to increase the probability of a successful Phase 2 clinical trial for us and that study is ongoing." This is about trial design, not about a recognition gap. For CA170: "Later this quarter, we expect CA170 to become the world's first orally administered checkpoint targeting immunooncology drug candidate to enter the clinic." This is forward-looking, not about a recognition gap. For Erivedge: "We are pleased to note that Roche has initiated enrollment in two clinical studies with Erivedge outside of BCC." This is about partner activities. Now, is there any statement where management says outsiders are underweighting something? Let me search for any such framing. I don't see any statement about how the company is perceived, valued, measured, or modeled. There's no statement like "investors are still anchored to..." or "the market doesn't appreciate..." or "the reported figures understate..." The call is essentially a progress update on clinical programs. Management reports on: 1. CUDC-907 Phase 2 trial ongoing, with MYC enrichment 2.
NO Substance without an audience: strong current business reported into a thin, shallow professional crowd
Original model output from the research archive. It may be verbose or include the model's working notes.
We need answer YES/NO. Need evaluate both halves. Transcript: Curis Q1 2016 earnings call. Management reports progress: CUDC-907 Phase 2 ongoing, completed enrollment monotherapy arm Phase 1, 8 objective responses out of 19 evaluable, correlation with MYC alterations. CA170 expected to enter clinic later this quarter (first oral checkpoint antagonist). Erivedge partner Roche initiated two studies. Financials: net loss $9.4M vs $31.8M prior year due one-time charge. Revenues $1.7M. R&D increased. Cash $73.1M. Is this "genuinely strong, concrete current business"? It's clinical development progress, not commercial operating strength like orders/customers. It's pipeline progress. The question asks "real, present-tense operating strength in recent period—such as growing orders, customers, volumes, output, utilization, wins, deployments, or activity, described with specific operating substance." For biotech, clinical trial enrollment and responses are current activity. But is it "strong"? They report completed enrollment, responses, correlation. However, it's still clinical trial, not revenue. The company has revenues $1.7M royalties. No growth. The reported strength is mostly pipeline and plans. The question specifically says NO if strength rests mainly on hopes, plans, pipeline, or market-size claims rather than business already happening. Here management discusses clinical trial progress, which is current activity but not commercial business. Also CA170 is expected to enter clinic later this quarter—plan. CUDC-907 Phase 2 ongoing. Is that "concrete current business"? It's R&D activity. The prompt asks "operating substance (who, what, how much, or what changed)"—they give numbers: 25 patients, 8 responses, 19 evaluable. That is concrete. But is it "strong"? It's positive clinical data. However, the company is a development-stage biotech with no product revenue except royalties. The "business" is drug development. The call reports progress. But the question's first half requires "genuinely strong, concrete current business" such as growing orders, customers, volumes, output, utilization, wins, deployments, or activity. Clinical trial enrollment and responses could be "activity" and "wins". But is it "present-tense operating strength"? They report completed enrollment, ongoing Phase 2, expected CA170 entry. It's not generic optimism. So maybe yes.
NO Caught under-prepared by good news: the recent period outran what management had set up for, and they are visibly adjust
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to answer YES or NO based on the transcript. The question asks: Does management convey that the recent period's business came in stronger, faster, or bigger than what the company had set itself up for, and is management now visibly adjusting the company in response to catch up with that favorable surprise? We need to look for evidence in the transcript. The company is Curis, a biotech. They have programs: CUDC-907, CA170, Erivedge. The call is about Q1 2016 results. Management discusses progress. For CUDC-907, they completed enrollment in monotherapy arm, and they report responses. They mention a retrospective analysis correlating responses with MYC alterations. They designed Phase 2 to target MYC-altered patients. That seems like a planned adjustment based on data, but is it a surprise? They say "This clinical analysis is very exciting and is consistent with our preclinical findings." They designed Phase 2 accordingly. That is a response to data, but is it a surprise that outran preparations? They had a Phase 1, then designed Phase 2. That's normal. For CA170, they expect it to enter clinic later this quarter. They talk about it being first oral checkpoint inhibitor. No mention of demand or outrunning. For Erivedge, they note Roche initiated two studies outside BCC. That's just an update. Financial results: net loss $9.4M vs $31.8M prior year, but prior year had one-time charge. Revenues $1.7M same as prior year. No mention of beating expectations. The question is about "recent period's business came in stronger, faster, or bigger than what the company had set itself up for" and "management is now visibly adjusting the company in response." Look for any language about demand, enrollment, etc. They mention completing enrollment in Phase 1 monotherapy arm. They had 25 patients, 8 responses. They say "we have now completed the enrollment" - that's just a milestone. No indication that enrollment was faster than expected or that they were surprised by demand. They also mention "we expect this patient enrichment to increase the probability of a successful Phase 2" - that's a design change based on data, but not a surprise in terms of business outrunning preparations. There is no mention of supply, capacity, hiring, etc. They do mention increased headcount in R&D, but that's due to increased clinical activities, not necessarily a surprise.
NO Crossed from claiming to demonstrating: management marks its own before/after line with repeated, recent proof
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to determine if management conveys a recent crossing from claiming to demonstrating something, with repeated real events, and management draws the before/after contrast. Let's analyze the transcript. The call covers CUDC-907 and CA170. For CUDC-907, they have completed enrollment in monotherapy arm, and report 8 objective responses out of 19 evaluable patients. They also mention a retrospective analysis correlating responses with MYC alterations. They designed Phase 2 to target MYC-altered patients. This is ongoing. They also have a solid tumor trial limited to MYC alterations or NUT midline carcinoma. For CA170, they expect it to become the world's first orally administered checkpoint targeting drug candidate to enter the clinic later this quarter. So it's not yet in clinic; it's expected. So that's future. The question asks: Does management convey that the company has recently crossed from claiming something to demonstrating it — that a capability, offering, or way of doing business which until recently existed mainly as a promise, plan, or early attempt is now something the company has actually done, and done more than once, in the recent period — with management itself drawing the before-versus-now contrast? We need to find a specific instance where management contrasts a past state (promise/plan) with a present state (actual repeated demonstration). Look for phrases like "we used to talk about whether we could; now we are doing it routinely" or similar. In the transcript, for CUDC-907, they present updated data from Phase 1. They say: "As of today, we have now completed the enrollment in the monotherapy arm of the Phase 1 and of the total 25 patients in this arm of the study, eight patients have experienced an objective response out of the total 19 response evaluable patients." This is a result, but is it a crossing from claiming to demonstrating? They had previously presented Phase 1 data at ASH in December. So they are updating. They also mention a retrospective analysis correlating responses with MYC alterations. This is new analysis. But is there a before/after contrast? They say "This clinical analysis is very exciting and is consistent with our preclinical findings..." They don't explicitly say "we used to only have preclinical data, now we have clinical data" in a way that draws a line. They are just reporting results.
NO Trajectory bent upward recently, and management says the change has only started showing
Original model output from the research archive. It may be verbose or include the model's working notes.
We need answer YES/NO. Need analyze transcript. Need determine if management conveys recent upward bend and still early. Need only transcript. Let's parse. Company Curis Q1 2016. Programs: CUDC-907 Phase 2 trial ongoing. Phase 1 results: last Dec ASH reported 7 objective responses out of 16 evaluable. As of today, completed enrollment in monotherapy arm Phase 1, total 25 patients, 8 objective responses out of 19 response evaluable. Note not include one CR in combination. Retrospective analysis indicates clinical benefit may relate to MYC inhibition. Designed Phase 2 to specifically treat ~1/3 DLBCL patients with MYC alterations. Expect enrichment increase probability. Solid tumor Phase 1 limited enrollment to MYC altered or NUT midline carcinoma. CA170: first orally administered small molecule checkpoint antagonist. Later this quarter, expect CA170 to become world's first orally administered checkpoint targeting IO drug candidate to enter clinic. Phase 1 expected to enroll advanced solid tumors including naive and refractory/relapsed on anti-checkpoint. Erivedge: partners Genentech/Roche. Roche initiated enrollment in two clinical studies outside BCC: myelofibrosis with ruxolitinib, IPF with pirfenidone. Financials: Q1 2016 net loss $9.4M vs $31.8M prior year (includes one-time IP R&D $24.3M). Revenues $1.7M each quarter. R&D expenses increased due to CUDC-907 Phase 2 trial initiated Jan 2016 and Aurigene collaboration. Cash $73.1M. Question asks: Does management convey trajectory has recently bent upward — within last few quarters something real changed in how business performing, current direction meaningfully better than before — AND management indicates change still early, most effect not yet visible in results? Need decide. The transcript is mostly updates on clinical programs. Is there a "recent bend" in business performance? Maybe CUDC-907 Phase 1 data improved from 7/16 to 8/19? That's modest. They completed enrollment, identified MYC biomarker, designed Phase 2 enriched. But is that a "real change in how business is performing" financially? No. Revenues flat $1.7M. Net loss improved due to one-time prior year charge, not operational. R&D increased. No product sales. Clinical progress not "business performance" in sense of orders/customers/revenue. The question asks "company's trajectory has recently bent upward" with examples.
NO The open question just closed: management treats a doubt that used to hang over the business as now answered, and names
Original model output from the research archive. It may be verbose or include the model's working notes.
We need answer YES/NO based on transcript. Need identify if management acknowledges specific doubt/open question that until recently hung over business, and conveys now answered in company's favor with concrete recent evidence. Let's examine transcript. Management (Ali Fattaey) discusses CUDC-907 Phase 1/2, CA170, Erivedge. They mention "retrospective analysis... indicates clinical benefit may be related to inhibition of MYC oncogene... correlation between patients who reported objective responses and DLBCL tumors harboring alterations in MYC... This clinical analysis is very exciting and is consistent with preclinical findings... In light of these findings, we designed our Phase 2 study... to specifically treat roughly one-third of DLBCL patients who have MYC alterations... We expect this patient enrichment to increase probability of successful Phase 2." This is not exactly acknowledging a prior doubt that is now resolved; it's presenting new data that supports a hypothesis. But is there a specific doubt? They say "clinical analysis is very exciting" - not "we previously doubted whether MYC was the mechanism, now proven." They are still in Phase 2 ongoing. The doubt about whether CUDC-907 works in MYC-altered patients? They have Phase 1 data showing responses. But they don't explicitly say "this was an open question until recently." They say "retrospective analysis indicates" - that's evidence. But is it a settled question? They designed Phase 2 based on it. However, they don't frame it as "we used to wonder if..." They are presenting findings. The question asks: "does management identify a SPECIFIC DOUBT OR OPEN QUESTION that until recently hung over the business — something that was genuinely uncertain or unproven about the company in the recent past — and convey that this question has NOW BEEN ANSWERED IN THE COMPANY'S FAVOR, pointing to real, recent evidence from the business itself as what settled it?" Look for any such. Maybe about CA170 being first oral checkpoint inhibitor? They say "Later this quarter, we expect CA170 to become the world's first orally administered checkpoint targeting immunooncology drug candidate to enter the clinic." That's future, not resolved. No. About Erivedge: "Roche has initiated enrollment in two clinical studies with Erivedge outside of BCC." That's new, not resolving doubt. About financials: no.
NO Ground-level proof points accumulating: management narrates several small, named, recent wins and treats them as the lea
Original model output from the research archive. It may be verbose or include the model's working notes.
We need answer YES/NO. Need analyze transcript. Need determine if management's account rests on several small concrete ground-level wins individually named/described, and explicitly treats as leading edge of broader improvement still early. Transcript: Curis Q1 2016. Programs: CUDC-907 Phase 2 trial ongoing, Phase 1 results. CA170 entering clinic. Erivedge partner initiated two studies. Financials. Need identify episodes from recent period. Management mentions: - Completed enrollment in monotherapy arm of Phase 1 CUDC-907; 25 patients, 8 objective responses out of 19 evaluable. This is an aggregate trial result, not ground-level episode? It's a milestone but not individual customer/site. - Retrospective analysis indicates clinical benefit related to MYC inhibition; correlation. That's a finding. - Designed Phase 2 to treat MYC altered DLBCL; ongoing. - Solid tumor Phase 1 limited enrollment to MYC altered or NUT midline carcinoma. - CA170 expected to enter clinic later this quarter. That's future, not happened. - Roche initiated enrollment in two clinical studies with Erivedge outside BCC: one in myelofibrosis with ruxolitinib, one in IPF with pirfenidone. These are specific recent episodes: Roche initiated enrollment in two studies. Are these "wins"? They are partner-initiated studies, not necessarily business wins but concrete events. - Financial results: net loss, revenues, expenses. Question asks: "management's account of the just-reported period rest on SEVERAL SMALL, CONCRETE, GROUND-LEVEL WINS THAT IT NAMES AND DESCRIBES INDIVIDUALLY — specific recent episodes from inside the business, each one identifiable on its own — AND does management explicitly treat these accumulating episodes as the LEADING EDGE of a broader improvement that is still early?" Need answer YES only if both halves. Here management's positive story is mostly about clinical trial progress, not "wins" like customers. Episodes: completion of enrollment in Phase 1 monotherapy arm, retrospective analysis, Phase 2 initiation, CA170 expected entry, Roche initiated two studies. Are these "small concrete ground-level wins"? They are specific events. But are they "wins"? Maybe. However, management does not explicitly connect them into a broader improvement still early. They describe progress but not as leading edge of broader improvement. Also many are future/plans.
Showing the latest 18 of 233 archived research questions.
These archived questions are separate from the newer 500-check scan above.
CRIS call history
Open a quarter only when you want its detailed evidence.
D Q1 2025 · Weak call · 2025-05-06Management gave no formal guidance against steady demand. The delivery was rich in specifics.
C Q4 2024 · Caution · 2025-03-31Management held guidance steady against accelerating demand. The delivery was rich in specifics, relaxed under questioning.
View the 20 core call-quality checks
D Q3 2024 · Weak call · 2024-11-14Management gave no formal guidance.
View the 20 core call-quality checks
D Q2 2024 · Weak call · 2024-08-01Management gave no formal guidance against contracting margins. The delivery was rich in specifics.
View the 20 core call-quality checks
D Q1 2024 · Weak call · 2024-05-07Management gave no formal guidance against accelerating demand. The delivery was unusually candid, promotional in tone.
View the 20 core call-quality checks
C Q4 2023 · Caution · 2024-02-08Management gave no formal guidance. The delivery was unusually candid, rich in specifics, relaxed under questioning.
View the 20 core call-quality checks
C Q3 2023 · Caution · 2023-11-02Management gave no formal guidance. The delivery was unusually candid, rich in specifics.
View the 20 core call-quality checks
View 32 earlier calls
| Call | Date | Grade | Guidance | Demand | Margins | Candor | Evasion |
|---|---|---|---|---|---|---|---|
| Q2 2023 | 2023-08-03 | C | none | unclear | expanding | 7/9 | 1/9 |
| Q1 2023 | 2023-05-04 | D | none | unclear | unclear | 7/9 | 5/9 |
| Q4 2022 | 2023-03-13 | C | maintained | unclear | contracting | 7/9 | 2/9 |
| Q3 2022 | 2022-11-09 | C+ | raised | unclear | contracting | 7/9 | 3/9 |
| Q2 2022 | 2022-08-05 | F | maintained | unclear | contracting | 7/9 | 3/9 |
| Q1 2022 | 2022-05-05 | F | maintained | unclear | contracting | 7/9 | 5/9 |
| Q4 2021 | 2022-02-24 | D | none | unclear | contracting | 6/9 | 2/9 |
| Q3 2021 | 2021-11-09 | D | none | unclear | contracting | 6/9 | 3/9 |
| Q2 2021 | 2021-08-03 | D | none | unclear | contracting | 6/9 | 4/9 |
| Q1 2021 | 2021-05-12 | F | none | unclear | unclear | 7/9 | 5/9 |
| Q4 2020 | 2021-03-16 | D | none | accelerating | unclear | 6/9 | 3/9 |
| Q3 2020 | 2020-11-10 | D | none | unclear | stable | 6/9 | 4/9 |
| Q3 2020 | 2020-11-10 | D | none | unclear | stable | 6/9 | 2/9 |
| Q2 2020 | 2020-08-04 | D | maintained | unclear | stable | 7/9 | 3/9 |
| Q1 2020 | 2020-05-12 | D | maintained | slowing | contracting | 6/9 | 2/9 |
| Q4 2019 | 2020-03-19 | D | none | unclear | contracting | 7/9 | 2/9 |
| Q3 2019 | 2019-11-05 | D | maintained | unclear | contracting | 8/9 | 3/9 |
| Q2 2019 | 2019-08-06 | D | maintained | unclear | unclear | 7/9 | 2/9 |
| Q1 2019 | 2019-05-14 | C | maintained | unclear | expanding | 6/9 | 1/9 |
| Q4 2018 | 2019-03-26 | C+ | maintained | unclear | expanding | 7/9 | 2/9 |
| Q3 2018 | 2018-11-01 | F | lowered | unclear | contracting | 7/9 | 3/9 |
| Q2 2018 | 2018-08-02 | D | none | unclear | unclear | 6/9 | 3/9 |
| Q1 2018 | 2018-05-03 | F | none | unclear | contracting | 4/9 | 5/9 |
| Q4 2017 | 2018-03-08 | D | none | unclear | unclear | 7/9 | 4/9 |
| Q3 2017 | 2017-11-07 | C | none | unclear | contracting | 7/9 | 2/9 |
| Q2 2017 | 2017-08-03 | D | none | unclear | unclear | 8/9 | 3/9 |
| Q1 2017 | 2017-05-04 | D | maintained | unclear | contracting | 6/9 | 2/9 |
| Q4 2016 | 2017-03-09 | D | none | unclear | contracting | 6/9 | 2/9 |
| Q3 2016 | 2016-11-03 | D | none | unclear | contracting | 6/9 | 3/9 |
| Q2 2016 | 2016-08-04 | D | none | unclear | contracting | 6/9 | 4/9 |
| Q1 2016 | 2016-05-09 | C | none | unclear | unclear | 6/9 | 3/9 |
| Q4 2015 | 2016-02-29 | C | maintained | unclear | contracting | 6/9 | 2/9 |